✦ LIBER ✦

Ketoprofen in piglets: enantioselective pharmacokinetics, pharmacodynamics and PK/PD modelling

✍ Scribed by T. K. FOSSE; P. L. TOUTAIN; C. SPADAVECCHIA; H. A. HAGA; T. E. HORSBERG; B. RANHEIM

Book ID: 108885559
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 381 KB
Volume: 34
Category: Article
ISSN: 0140-7783
DOI: 10.1111/j.1365-2885.2010.01236.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of pharmacodynamic baseline chang

Effect of pharmacodynamic baseline changes in linked & indirect pharmacokinetic-pharmacodynamic (PK-PD) models.

✍ Young, D.; Piscitelli, D.A. 📂 Article 📅 1996 🏛 Nature Publishing Group 🌐 English ⚖ 171 KB

Enantioselective pharmacokinetics of ket

Enantioselective pharmacokinetics of ketoprofen in piglets: the significance of neonatal age

✍ T. K. FOSSE; T. E. HORSBERG; H. A. HAGA; V. HORMAZABAL; B. RANHEIM 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

PIII-60 Pharmacokinetics and Pharmacodyn

PIII-60 Pharmacokinetics and Pharmacodynamics (PK/PD) of Terazosin in Hypertensive Patients

✍ Hosmane, B.; Granneman, R.; Achari, R. 📂 Article 📅 1996 🏛 Nature Publishing Group 🌐 English ⚖ 122 KB

Pharmacokinetics (PK) and CNS Pharmacody

Pharmacokinetics (PK) and CNS Pharmacodynamics (PD) of Buspirone in a Human Experimental Model of Depression

✍ Jagannathan, V.; Venitz, J. 📂 Article 📅 1996 🏛 Nature Publishing Group 🌐 English ⚖ 135 KB

Pharmacokinetics (PK) and Pharmacodynami

Pharmacokinetics (PK) and Pharmacodynamics (PD) of Growth Hormone Releasing Peptide-2 (GHRP) in Children

✍ Kearns, G.; Pihoker, C.; Bowers, C. 📂 Article 📅 1996 🏛 Nature Publishing Group 🌐 English ⚖ 149 KB

A combined pharmacokinetic–pharmacodynam

A combined pharmacokinetic–pharmacodynamic (PK–PD) model for tumor growth in the rat with UFT administration

✍ Jong Hwan Sung; Anjali Dhiman; Michael L. Shuler 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB

A combined pharmacokinetic-pharmacodynamic model was developed to simulate the response of a rat tumor to UFT, a combination of uracil with Tegafur (FT). Tegafur is oral the prodrug of 5-fluorouracil (5-FU), an anti-cancer drug for colon cancer. A physiologically based pharmacokinetic (PBPK) model w